reference/29164528

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29164528

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1479-5876
issueIdentifier	1
pageRange	17-
publicationName	Journal of Translational Medicine
startingPage	17
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4d0b9f77b45ccd2c7ef27f564f1cfe57 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_128a54858c94322a22fe100754f3b35f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e99b4f38994c13e1fcf4692443606969 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f45233d8b45d44d2d78f0319c68e02aa http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f970bf1a8a27f190da4710fdc81bb3ff http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_93cc3488aec06d78eb5f3995d8f19a5e http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c5d1e8fec1c588e04bb5010f1d0d6c06 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a0cd648430cc097fa6c5be3232e05e8c
bibliographicCitation	Lin Y, Zhang J, Li Y, Guo W, Chen L, Chen M, Chen X, Zhang W, Jin X, Jiang M, Xiao H, Wang C, Song C, Fu F. CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1. Journal of Translational Medicine. 2022 Jan 06;20(1):17. doi: 10.1186/s12967-021-03206-5.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af37f448a85f584c75bf3ce29f01754f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3095b886a5f955fd33314e78d7ef1b74 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43a7132430d714d3b406bf9772b650bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3065-5708 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20d2808f4144452f04a4c696638d7a4d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b954baf86ee02fa23a94a70f1f89470 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b679e9684a79231fc7d537c94c1243b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5664-3721 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36a00f5a8d2a23e16e746afdcebf6db4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06a822ab37f9d0a945519853250a3715 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd908e95d3fc3bbfec672ffce489835f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7c6fa511974c1db70fda4ab523020c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06bd929857d845d212909f3067fdf8ad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_637a5b8ec7e5b5d8fa3d9e2a78dc94bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ad50d9cc8b1ab3d36730f1f73941101
date	2022-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8734240 https://pubmed.ncbi.nlm.nih.gov/34991621 https://doi.org/10.1186/s12967-021-03206-5
isPartOf	https://portal.issn.org/resource/ISSN/1479-5876 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/31680
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
discusses	http://id.nlm.nih.gov/mesh/M0192760 http://id.nlm.nih.gov/mesh/M0015075 http://id.nlm.nih.gov/mesh/M0124261 http://id.nlm.nih.gov/mesh/M0005577
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.13.12.8 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6175 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1ad0f1b3b379747d7829e994c31446d1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52e765c78c66ef6dd5d8602242756a45 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4904 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1503

Total number of triples: 54.